Rice Hall James & Associates, LLC Veracyte, Inc. Transaction History
Rice Hall James & Associates, LLC
- $1.66 Billion
- Q4 2024
A detailed history of Rice Hall James & Associates, LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Rice Hall James & Associates, LLC holds 95,615 shares of VCYT stock, worth $4.31 Million. This represents 0.23% of its overall portfolio holdings.
Number of Shares
95,615
Previous 127,190
24.83%
Holding current value
$4.31 Million
Previous $4.33 Million
12.52%
% of portfolio
0.23%
Previous 0.26%
Shares
2 transactions
Others Institutions Holding VCYT
# of Institutions
316Shares Held
81.8MCall Options Held
134KPut Options Held
13.3K-
Black Rock Inc. New York, NY7.79MShares$351 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.75MShares$349 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI5.02MShares$226 Million0.27% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.92MShares$222 Million1.59% of portfolio
-
Wellington Management Group LLP Boston, MA4.23MShares$191 Million0.03% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $3.23B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...